Oncology Rising 50

Oncology ventures dominated digital health landscape, raised significant funding, and forming strong partnerships in the last 5 years. This list ranks the most promising Oncology focused Early-Stage Digital Health ventures. Using our proprietary platform HealthTech Alpha, the largest aggregator for Digital Health ventures with more than 12,500 ventures globally, we have developed a selection algorithm that ranked the ventures based on indices, including our proprietary Alpha Score, recent partnerships, news sentiment, clinical strength, key team members, regulatory approvals, and clinical strength.For a complete analysis of Oncology Ventures, download your own copy of Galen Growth’s https://www.healthtechalpha.com/research/digital-health-in-oncology

Last Updated: May 23, 2023

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
AI Metrics	Medical Imaging	United States	$ 123.46 B	$ 123.46 B	Seed	$ 1.16 M
Aignostics	Medical Imaging	Germany	$ 123.46 B	$ 123.46 B	Series A	$ 14.01 M
Alpenglow Biosciences	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	Series A1	$ 1.00 M
ArcaScience	Drug Discovery	France	$ 123.46 B	$ 123.46 B	Grant	$ 0.00 M
Baobab AiBio (바오밥에이바이오)	Drug Discovery	South Korea	$ 123.46 B	$ 123.46 B	Series A1	$ 2.70 M
Biofidelity	Omics Related Diagnosis	United Kingdom	$ 123.46 B	$ 123.46 B	Series B	$ 24.00 M
Blue Note Therapeutics	Digital Therapeutics	United States	$ 123.46 B	$ 123.46 B	Series A1	$ 5.20 M
Cispoly (聚禾生物)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	Series B	$ 14.03 M
contextflow	Medical Imaging	Austria	$ 123.46 B	$ 123.46 B	Series A1	$ 2.28 M
Cyted	Prescriptive Analytics	United Kingdom	$ 123.46 B	$ 123.46 B	Series A	$ 16.62 M

Showing 1 to 10 of 49 entries